메뉴 건너뛰기




Volumn 190, Issue 8, 2013, Pages 3854-3858

Cutting edge: Rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the flumist vaccine

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

EID: 84875967881     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202790     Document Type: Article
Times cited : (36)

References (28)
  • 2
    • 84155162558 scopus 로고    scopus 로고
    • Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis
    • Osterholm, M. T., N. S. Kelley, A. Sommer, and E. A. Belongia. 2012. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12: 36-44.
    • (2012) Lancet Infect. Dis. , vol.12 , pp. 36-44
    • Osterholm, M.T.1    Kelley, N.S.2    Sommer, A.3    Belongia, E.A.4
  • 7
    • 10544256245 scopus 로고
    • Infection of the upper respiratory tract of mice with influenza A virus
    • Iida, T., and F. B. Bang. 1963. Infection of the upper respiratory tract of mice with influenza A virus. Am. J. Hyg. 77: 169-176.
    • (1963) Am. J. Hyg. , vol.77 , pp. 169-176
    • Iida, T.1    Bang, F.B.2
  • 8
    • 28844456504 scopus 로고    scopus 로고
    • Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression
    • Legge, K. L., and T. J. Braciale. 2005. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 23: 649-659.
    • (2005) Immunity , vol.23 , pp. 649-659
    • Legge, K.L.1    Braciale, T.J.2
  • 9
    • 84861302929 scopus 로고    scopus 로고
    • Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses
    • Jang, Y. H., Y. H. Byun, Y. J. Lee, Y. H. Lee, K. H. Lee, and B. L. Seong. 2012. Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses. J. Virol. 86: 5953-5958.
    • (2012) J. Virol. , vol.86 , pp. 5953-5958
    • Jang, Y.H.1    Byun, Y.H.2    Lee, Y.J.3    Lee, Y.H.4    Lee, K.H.5    Seong, B.L.6
  • 10
    • 0034469764 scopus 로고    scopus 로고
    • Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory
    • Christensen, J. P., P. C. Doherty, K. C. Branum, and J. M. Riberdy. 2000. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J. Virol. 74: 11690-11696.
    • (2000) J. Virol. , vol.74 , pp. 11690-11696
    • Christensen, J.P.1    Doherty, P.C.2    Branum, K.C.3    Riberdy, J.M.4
  • 11
    • 0842324614 scopus 로고    scopus 로고
    • Jump-starting the immune system: Prime-boosting comes of age
    • Woodland, D. L. 2004. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 25: 98-104.
    • (2004) Trends Immunol. , vol.25 , pp. 98-104
    • Woodland, D.L.1
  • 12
    • 79960565908 scopus 로고    scopus 로고
    • Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: Efficacy against repeated mucosal R5 clade C SHIV challenges
    • Lakhashe, S. K., V. Velu, G. Sciaranghella, N. B. Siddappa, J. M. Dipasquale, G. Hemashettar, J. K. Yoon, R. A. Rasmussen, F. Yang, S. J. Lee, et al. 2011. Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine 29: 5611-5622.
    • (2011) Vaccine , vol.29 , pp. 5611-5622
    • Lakhashe, S.K.1    Velu, V.2    Sciaranghella, G.3    Siddappa, N.B.4    Dipasquale, J.M.5    Hemashettar, G.6    Yoon, J.K.7    Rasmussen, R.A.8    Yang, F.9    Lee, S.J.10
  • 13
    • 84856519280 scopus 로고    scopus 로고
    • A live-attenuated listeria vaccine (ANZ-100) and a live-attenuated listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: Phase I studies of safety and immune induction
    • Le, D. T., D. G. Brockstedt, R. Nir-Paz, J. Hampl, S. Mathur, J. Nemunaitis, D. H. Sterman, R. Hassan, E. Lutz, B. Moyer, et al. 2012. A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin. Cancer Res. 18: 858-868.
    • (2012) Clin. Cancer Res. , vol.18 , pp. 858-868
    • Le, D.T.1    Brockstedt, D.G.2    Nir-Paz, R.3    Hampl, J.4    Mathur, S.5    Nemunaitis, J.6    Sterman, D.H.7    Hassan, R.8    Lutz, E.9    Moyer, B.10
  • 14
    • 33846540410 scopus 로고    scopus 로고
    • Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo
    • Sanchez, P. J., J. A. McWilliams, C. Haluszczak, H. Yagita, and R. M. Kedl. 2007. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 178: 1564-1572.
    • (2007) J. Immunol. , vol.178 , pp. 1564-1572
    • Sanchez, P.J.1    McWilliams, J.A.2    Haluszczak, C.3    Yagita, H.4    Kedl, R.M.5
  • 15
    • 77954122878 scopus 로고    scopus 로고
    • Modulating numbers and phenotype of CD8+ T cells in secondary immune responses
    • Wirth, T. C., J. T. Harty, and V. P. Badovinac. 2010. Modulating numbers and phenotype of CD8+ T cells in secondary immune responses. Eur. J. Immunol. 40: 1916-1926.
    • (2010) Eur. J. Immunol. , vol.40 , pp. 1916-1926
    • Wirth, T.C.1    Harty, J.T.2    Badovinac, V.P.3
  • 16
    • 64849085607 scopus 로고    scopus 로고
    • Programming for CD8 T cell memory development requires IL-12 or type I IFN
    • Xiao, Z., K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F. Mescher. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J. Immunol. 182: 2786-2794.
    • (2009) J. Immunol. , vol.182 , pp. 2786-2794
    • Xiao, Z.1    Casey, K.A.2    Jameson, S.C.3    Curtsinger, J.M.4    Mescher, M.F.5
  • 17
    • 34548027000 scopus 로고    scopus 로고
    • Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor
    • Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
    • (2007) Immunity , vol.27 , pp. 281-295
    • Joshi, N.S.1    Cui, W.2    Chandele, A.3    Lee, H.K.4    Urso, D.R.5    Hagman, J.6    Gapin, L.7    Kaech, S.M.8
  • 18
    • 41149099559 scopus 로고    scopus 로고
    • Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates
    • Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.
    • (2008) J. Exp. Med. , vol.205 , pp. 625-640
    • Sarkar, S.1    Kalia, V.2    Haining, W.N.3    Konieczny, B.T.4    Subramaniam, S.5    Ahmed, R.6
  • 19
    • 0017714040 scopus 로고
    • Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses
    • Zweerink, H. J., S. A. Courtneidge, J. J. Skehel, M. J. Crumpton, and B. A. Askonas. 1977. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature 267: 354-356.
    • (1977) Nature , vol.267 , pp. 354-356
    • Zweerink, H.J.1    Courtneidge, S.A.2    Skehel, J.J.3    Crumpton, M.J.4    Askonas, B.A.5
  • 21
    • 80052015820 scopus 로고    scopus 로고
    • Live attenuated influenza vaccine (Flu-mist®; fluenz™): A review of its use in the prevention of seasonal influenza in children and adults
    • Carter, N. J., and M. P. Curran. 2011. Live attenuated influenza vaccine (Flu-Mist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 71: 1591-1622.
    • (2011) Drugs , vol.71 , pp. 1591-1622
    • Carter, N.J.1    Curran, M.P.2
  • 22
    • 79955119194 scopus 로고    scopus 로고
    • A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older
    • Forrest, B. D., A. D. Steele, L. Hiemstra, R. Rappaport, C. S. Ambrose, and W. C. Gruber. 2011. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Vaccine 29: 3633-3639.
    • (2011) Vaccine , vol.29 , pp. 3633-3639
    • Forrest, B.D.1    Steele, A.D.2    Hiemstra, L.3    Rappaport, R.4    Ambrose, C.S.5    Gruber, W.C.6
  • 25
    • 70349864985 scopus 로고    scopus 로고
    • Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus
    • Bridle, B. W., J. E. Boudreau, B. D. Lichty, J. Brunellière, K. Stephenson, S. Koshy, J. L. Bramson, and Y. Wan. 2009. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. Mol Ther. 17: 1814-1821.
    • (2009) Mol Ther. , vol.17 , pp. 1814-1821
    • Bridle, B.W.1    Boudreau, J.E.2    Lichty, B.D.3    Brunellière, J.4    Stephenson, K.5    Koshy, S.6    Bramson, J.L.7    Wan, Y.8
  • 26
    • 22544448946 scopus 로고    scopus 로고
    • Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination
    • Badovinac, V. P., K. A. Messingham, A. Jabbari, J. S. Haring, and J. T. Harty. 2005. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11: 748-756.
    • (2005) Nat. Med. , vol.11 , pp. 748-756
    • Badovinac, V.P.1    Messingham, K.A.2    Jabbari, A.3    Haring, J.S.4    Harty, J.T.5
  • 27
    • 84864020108 scopus 로고    scopus 로고
    • Signal 3 cytokines as modulators of primary immune responses during infections: The interplay of type I IFN and IL-12 in CD8 T cell responses
    • Keppler, S. J., K. Rosenits, T. Koegl, S. Vucikuja, and P. Aichele. 2012. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS ONE 7: e40865.
    • (2012) PLoS ONE , vol.7
    • Keppler, S.J.1    Rosenits, K.2    Koegl, T.3    Vucikuja, S.4    Aichele, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.